Oncology Corporate Profile
RedHill Biopharma Ltd, is an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary drugs for the treatment of inflammatory and gastrointestinal diseases, including cancer.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|RP101||Hsp127 inhibitor||Pancreatic cancer||II|
|ABC294640||sphingosine kinase inhibitor||Diffuse large B-cell Lymphoma (DLBCL)||I|
|ABC294640 (+ YELIVA®)||sphingosine kinase inhibitor||Multiple Myeloma||I|
|mesupron||urokinase-type plasminogen (uPA) inhibitor||Various cancer types||I|
View additional information on product candidates here »